SCHEMBL25508982

SCHEMBL25508982

c1ccc(-c2ccc3ccc(-c4nc(-c5ccc6ccccc6c5)nc(-c5cncc6oc7ccccc7c56)n4)cc3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.39
CYP11B2 P19099 4/20 0.39
CYP17A1 P05093 1/20 0.39
CYP19A1 P11511 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2B6 P20813 1/20 0.38
CYP2C19 P33261 1/20 0.38
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 3/20 0.36
TP53 P04637 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ESR1 P03372 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25508981 0.99 CYP11B1 (0.40) CYP11B1CYP11B2CYP17A1CYP19A1CYP1A2
SCHEMBL25508741 0.96 KDM4E (0.40) CYP11B1CYP11B2CYP17A1CYP19A1CYP1A2
SCHEMBL25508744 0.96 KDM4E (0.40) CYP11B1CYP11B2CYP17A1CYP19A1CYP1A2
SCHEMBL25509102 0.95 CYP11B1 (0.39) CYP11B1CYP11B2CYP17A1CYP19A1CYP1A2
SCHEMBL23946598 0.94 CYP11B1 (0.41) CYP11B1CYP11B2CYP17A1CYP19A1CYP1A2
SCHEMBL25508883 0.93 CYP11B1 (0.37) CYP11B1CYP11B2CYP17A1CYP19A1CYP1A2
SCHEMBL23946685 0.92 CYP11B1 (0.35) CYP11B1CYP11B2CYP17A1CYP19A1CYP1A2
SCHEMBL25508740 0.92 CYP11B1 (0.37) CYP11B1CYP11B2CYP17A1CYP19A1CYP1A2
SCHEMBL25508410 0.92 ALDH1A1 (0.35) CYP11B1CYP11B2CYP17A1CYP19A1CYP1A2
SCHEMBL25504537 0.90 ALDH1A1 (0.36) CYP11B1CYP11B2CYP17A1CYP19A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237518-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-07-11 US disclosed
US-20240237518-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-07-11 US disclosed
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-06-27 US disclosed
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-06-08 US disclosed
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-06-08 US disclosed
WO-2023090836-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-25 WO disclosed
WO-2023085878-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-19 WO disclosed
WO-2023085908-A1 ORGANIC LIGHT EMITTING DEVICE 주식회사 엘지화학 2023-05-19 WO disclosed
WO-2023085881-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY2, CYBA, AHR CYP11B1 1001/4885CYP11B2 1023/4885CYP17A1 1140/4885
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, CRY1, AHR CYP11B1 358/4885CYP11B2 359/4885CYP17A1 521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.